Key regions: Japan, India, Italy, Brazil, South Korea
The Anti-Hypertensive Drugs market in Mozambique has been experiencing growth in recent years.
Customer preferences: As in many other countries, the primary customers for Anti-Hypertensive Drugs in Mozambique are individuals who suffer from hypertension. In addition, healthcare providers such as hospitals and clinics also purchase these drugs to provide care for their patients.
Trends in the market: One trend that has been observed in the Anti-Hypertensive Drugs market in Mozambique is the increasing availability of generic drugs. This has led to increased competition among drug manufacturers, resulting in lower prices for consumers. In addition, there has been a shift towards more combination drugs, which offer multiple medications in a single pill. This is seen as a more convenient option for patients, as it can simplify their medication regimen.
Local special circumstances: Mozambique is a low-income country with a high burden of disease. Hypertension is a significant health issue in the country, with a prevalence of around 30%. This has led to increased demand for Anti-Hypertensive Drugs, as healthcare providers seek to manage the condition and prevent complications such as heart disease and stroke. However, access to healthcare in Mozambique is limited, particularly in rural areas. This can make it difficult for individuals to obtain the medications they need.
Underlying macroeconomic factors: Mozambique has experienced economic growth in recent years, driven by natural resources such as coal and gas. However, the country remains one of the poorest in the world, with a large proportion of the population living in poverty. This can limit the ability of individuals to access healthcare and purchase medications. In addition, Mozambique has a high burden of infectious diseases such as HIV/AIDS, which can divert resources away from non-communicable diseases such as hypertension.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
